Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection
Clinical trial NCT03468829 · WITHDRAWN
Trial details
- NCT number
- NCT03468829
- Sponsor
- Ablynx, a Sanofi company
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2020-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.